شیرین دارو
دشیری | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/06/16 Fiscal Year 2026/03/2012 Month | 2025/04/30 Fiscal Year 2025/03/2012 Month | 2024/07/14 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 323.344 Billion | 171.627 Billion | 295.441 Billion | |
Trade Receivables | 2.227 Trillion | 877.72 Billion | 1.483 Trillion | |
Prepayments | 4.118 Billion | 28.358 Billion | 6.622 Billion | |
Raw Materials & Packaging Inventory | 425.689 Billion | - | 740.29 Billion | |
Finished Goods Inventory | 1.283 Trillion | - | 590.251 Billion | |
Spare Parts Inventory | 65.053 Billion | - | 44.965 Billion | |
Other Inventories | - | 1.861 Trillion | - | |
Inventories | 1.774 Trillion | 1.861 Trillion | 1.376 Trillion | |
Total Current Assets | 4.328 Trillion | 2.938 Trillion | 3.161 Trillion | |
Long-Term Investments | 1 Million | 1 Million | 1 Million | |
Intangible Assets | 19.694 Billion | 4.166 Billion | 4.01 Billion | |
Other Assets | 5.5 Billion | 8.326 Billion | 8.277 Billion | |
Property, Plant & Equipment | 500.323 Billion | 407.515 Billion | 86.975 Billion | |
Net Fixed Assets | 500.323 Billion | 407.515 Billion | 86.975 Billion | |
Total Non-Current Assets | 525.518 Billion | 420.008 Billion | 99.263 Billion | |
Total Assets | 4.854 Trillion | 3.358 Trillion | 3.26 Trillion | |
Trade Payables | 253.057 Billion | 251.81 Billion | 246.997 Billion | |
Advances Received | 472 Million | 7.038 Billion | 2.211 Billion | |
Income Tax Provision | 3.828 Billion | 6.687 Billion | 232.693 Billion | |
Proposed & Payable Dividends | 1.127 Trillion | 665.999 Billion | 1.026 Trillion | |
Current Borrowings | 250.601 Billion | 53.833 Billion | 309.008 Billion | |
Total Current Liabilities | 1.635 Trillion | 985.367 Billion | 1.817 Trillion | |
Employee Termination Benefits Provision | 209.345 Billion | 145.987 Billion | 94.66 Billion | |
Total Non-Current Liabilities | 209.345 Billion | 145.987 Billion | 94.66 Billion | |
Total Liabilities | 1.844 Trillion | 1.131 Trillion | 1.912 Trillion | |
Capital | 50 Billion | 50 Billion | 50 Billion | |
Retained Earnings | 2.983 Trillion | 2.2 Trillion | 1.321 Trillion | |
Legal Reserve | 5 Billion | 5 Billion | 5 Billion | |
Share Premium Reserve | -28.433 Billion | -28.433 Billion | -28.454 Billion | |
Total Equity | 3.01 Trillion | 2.227 Trillion | 1.348 Trillion | |
Total Liabilities & Equity | 4.854 Trillion | 3.358 Trillion | 3.26 Trillion | |
Approved Capital | 50 Billion | 50 Billion | 50 Billion | |
Approved Retained Earnings | 983.165 Billion | 440.474 Billion | 601.472 Billion | |
Approved Legal Reserve | 5 Billion | 5 Billion | 5 Billion | |
Total Approved Equity (at AGM) | 1.038 Trillion | 495.474 Billion | 656.472 Billion |